With a grant from the Centers for Disease Control and Prevention, health officials will promote strategies to reduce dementia ...
In the United States, 7.2 million people are currently living with Alzheimer’s, with over 5 million of them being over the ...
South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...
British researchers said the findings, published in The Lancet Psychiatry, could give doctors a potential tool to spot those ...
Sanofi is back with its second pact of the day, this time announcing a licensing deal for a South Korean biotech’s antibody ...
UVA researchers found even minor trauma can disrupt the brain’s cleanup system, allowing harmful proteins to build up over ...
A new study suggests that hydrogen sulfide, a gas released by the body when you fart, could help protect the brain against ...
A drug approved to help slow the progression of Alzheimer’s is giving an Oklahoma couple hope. The drug is only for patients ...
Early signs of Alzheimer’s are often subtle and easy to overlook. Knowing these initial changes can help detect them sooner ...
New research shows that where a person lives can determine whether they receive timely diagnosis and care, or instead fall ...
Siemens Healthineers will utilize ALZpath's high-performing, proprietary pTau217 antibody in its growing test menu for its Atellica analyzers to enable ...
Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback